Spruce Biosciences Inc Live Stock Price Today, Share Analysis and Chart

Name: Spruce Biosciences Inc: Is Infosys Ltd. worth buying?
Item: Spruce Biosciences Inc
Rating: 1.60358325
Author: Trendlyne DVM scores

about

Spruce Biosciences Inc is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with unmet medical needs. The pipeline products of the company include Tralesinidase Alfa (TA-ERT)...

62.79 0.68 (1.09%)

73.84% Fall from 52W High

84,443.2

XNAS Volume

XNAS 10 Mar, 2026 4:01 PM (EDT)

Board Meeting

The board meeting for Spruce Biosciences Inc is scheduled for today, for the purpose of The Citizens Life Sciences Conference See details

Not Eligible

Expensive Valuation

4.8 / 100

Technically Neutral

59.3 / 100

198

1Yr Price target upside is 216%

4 analysts

Spruce Biosciences Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Spruce Biosciences Inc Live Stock Price Today, Share Analysis and Chart

Spruce Biosciences Inc is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with unmet medical needs. The pipeline products of the company include Tralesinidase Alfa (TA-ERT)...

73.84% Fall from 52W High

SWOT Analysis

Spruce Biosciences Inc Live Price Chart